EP Wealth Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 13,155 shares of the conglomerate’s stock, valued at approximately $9,472,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the second quarter worth $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the fourth quarter worth $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Stock Up 1.6%
DHR stock opened at $219.42 on Friday. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a fifty day simple moving average of $195.80 and a 200 day simple moving average of $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on DHR shares. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Finally, Evercore reissued an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
